Alex Kim
Head of People NewLimit
Seminars
In today’s high‑stakes biotech environment, every organization looks to HR for clarity, resilience, and leadership. CHROs are tasked with guiding their companies through scientific uncertainty, shifting market pressures, evolving workforce models, and constant change. But while HR is expected to have all the answers, the people at the top rarely have a dedicated space to ask their own questions.
This panel creates that space. Join an honest, senior‑level conversation designed exclusively for biotech CHROs who carry the weight of organizational wellbeing on their shoulders. This is an opportunity to step out of the role of constant problem‑solver and into a room of peers who truly understand your pressures, your constraints, and your challenges.
How to sustain culture during layoffs, funding volatility, and hybrid work, linking initiatives to measurable ROI.
- How leading biopharma organizations are protecting culture and psychological safety during layoffs, reorganizations, and funding volatility
- Practical approaches for preserving belonging and community in hybrid and distributed teams without increasing workload or cost
- What actually works: culture initiatives directly tied to measurable ROI such as retention, engagement uplift, productivity metrics, and reduced regretted attrition
